Advertisement
Singapore markets closed
  • Straits Times Index

    3,280.10
    -7.65 (-0.23%)
     
  • Nikkei

    37,934.76
    +306.28 (+0.81%)
     
  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • Bitcoin USD

    63,411.20
    -733.20 (-1.14%)
     
  • CMC Crypto 200

    1,322.63
    -73.90 (-5.07%)
     
  • S&P 500

    5,101.57
    +53.15 (+1.05%)
     
  • Dow

    38,246.87
    +161.07 (+0.42%)
     
  • Nasdaq

    15,926.55
    +314.79 (+2.02%)
     
  • Gold

    2,348.20
    +5.70 (+0.24%)
     
  • Crude Oil

    84.07
    +0.50 (+0.60%)
     
  • 10-Yr Bond

    4.6690
    -0.0370 (-0.79%)
     
  • FTSE Bursa Malaysia

    1,575.16
    +5.91 (+0.38%)
     
  • Jakarta Composite Index

    7,036.08
    -119.22 (-1.67%)
     
  • PSE Index

    6,628.75
    +53.87 (+0.82%)
     

How Novavax Could Shake Up the COVID Vaccine Market

Moderna (NASDAQ: MRNA), Johnson & Johnson (NYSE: JNJ), and Pfizer (NYSE: PFE) and its partner BioNTech (NASDAQ: BNTX) share the U.S. COVID-19 vaccine market right now. In this Motley Fool Live video recorded on July 21, healthcare and cannabis bureau editor-analyst Olivia Zitkus and Motley Fool contributor Keith Speights discuss how Novavax (NASDAQ: NVAX) could potentially shake up the COVID vaccine market.